期刊
PURINERGIC SIGNALLING
卷 8, 期 3, 页码 523-537出版社
SPRINGER
DOI: 10.1007/s11302-011-9282-3
关键词
ATP; Adenosine nucleotides; Purinergic signaling; Tissue injury; Differentiation; Immune system
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
- CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil [2006/61285-9]
- FAPERGS/CNPq - PRONEX, Brazil
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/61285-9] Funding Source: FAPESP
Replacement of lost or dysfunctional tissues by stem cells has recently raised many investigations on therapeutic applications. Purinergic signaling has been shown to regulate proliferation, differentiation, cell death, and successful engraftment of stem cells originated from diverse origins. Adenosine triphosphate release occurs in a controlled way by exocytosis, transporters, and lysosomes or in large amounts from damaged cells, which is then subsequently degraded into adenosine. Paracrine and autocrine mechanisms induced by immune responses present critical factors for the success of stem cell therapy. While P1 receptors generally exert beneficial effects including anti-inflammatory activity, P2 receptor-mediated actions depend on the subtype of stimulated receptors and localization of tissue repair. Pro-inflammatory actions and excitatory tissue damages mainly result from P2X7 receptor activation, while other purinergic receptor subtypes participate in proliferation and differentiation, thereby providing adequate niches for stem cell engraftment and novel mechanisms for cell therapy and endogenous tissue repair. Therapeutic applications based on regulation of purinergic signaling are foreseen for kidney and heart muscle regeneration, Clara-like cell replacement for pulmonary and bronchial epithelial cells as well as for induction of neurogenesis in case of neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据